Zydus Hospira Oncology Private Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Plot No.3, Pharmez, Special Economic Zone, Sarkhej Bavla Highway, Village Matoda, Taluka Sanand, Ahmedabad, Gujarat 382213, India (IND)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3007869619 · DUNS 676190889
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-06-30
- VAIDrug Quality Assurance2019-10-22
- VAIDrug Quality Assurance2018-04-12
- NAIDrug Quality Assurance2014-09-16
- NAIDrug Quality Assurance2012-07-26
Drugs this plant is listed as making
14 distinct drugs across 48 products name this site in their FDA label.
- BleomycinHospira, Inc.
- BortezomibZydus Pharmaceuticals USA Inc.
- CytarabineHospira, Inc.
- DocetaxelHospira, Inc.
- Docetaxel AnhydrousHospira, Inc.
- GemcitabineHospira, Inc.
- idarubicin hydrochloridePfizer Laboratories Div Pfizer Inc
- Irinotecan HydrochlorideHospira, Inc.
- MitoxantroneHospira, Inc.
- OxaliplatinHospira, Inc.
- PemetrexedHospira, Inc.
- pemetrexed disodiumZydus Lifesciences Limited
- TopotecanHospira, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.